Therapeutic effects of acupuncture with MOK, a polyherbal medicine, on PTU‑induced hypothyroidism in rats

Hwang,Ji  Hye; Jung,Hyo  Won; Kang,Seok  Yong; Kang,An  Na; Ma,Jun  Nan; Meng,Xiang  Long; Hwang,Min  Sub; Park,Yong‑Ki

doi:10.3892/etm.2018.6190

Therapeutic effects of acupuncture with MOK, a polyherbal medicine, on PTU‑induced hypothyroidism in rats

Authors:
- Ji Hye Hwang
- Hyo Won Jung
- Seok Yong Kang
- An Na Kang
- Jun Nan Ma
- Xiang Long Meng
- Min Sub Hwang
- Yong‑Ki Park
View Affiliations

Affiliations: Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Gachon University, Seongnam, Gyeonggi 13120, Republic of Korea, Department of Herbology, College of Korean Medicine, Dongguk University, Gyeongju, Gyeongbuk 38066, Republic of Korea, Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Dongguk University, Gyeongju, Gyeongbuk 38066, Republic of Korea
Published online on: May 18, 2018 https://doi.org/10.3892/etm.2018.6190
Pages: 310-320
Copyright: © Hwang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acupuncture with MOK, a polyherbal medicine (MOK pharmacopuncture), has been used for the treatment of thyroid syndromes including hypothyroidism and hyperthyroidism in traditional Korean medicine. The present study investigated the effect of MOK pharmacopuncture on hypothyroidism and the mechanism underlying its antioxidation and immune regulation effects. Hypothyroidism was induced in Sprague‑Dawley rats by subcutaneous injection of Propylthiouracil (PTU; 10 mg/kg) once daily for 4 weeks. MOK was administered by acupuncture on the acupoints around the thyroid gland of PTU‑induced hypothyroidism rats once daily for 2 weeks following hypothyroidism induction. Administration of MOK pharmacopuncture significantly increased the PTU‑induced decrease in body temperature of hypothyroidism rats. The weights of the spleen were also significantly decreased in hyperthyroidism rats following MOK pharmacopuncture. MOK pharmacopuncture significantly decreased the thyroid stimulating hormone level and increased the T3 and T4 levels in hypothyroidism rats. Administration of MOK pharmacopuncture significantly increased the glucose levels and decreased the levels of triglycerides, total cholesterol, low‑density lipoprotein‑cholesterol, and alanine transaminase in the sera of hypothyroidism rats. The expression of transient receptor potential cation channel subfamily V member 1 was increased in dorsal root ganglion and brain tissues by administration of MOK pharmacopuncture, and glutathione levels and the expression of superoxide dismutase 1 and catalase were increased in the liver and brain tissues. Administration of MOK pharmacopuncture significantly inhibited interferon‑γ expression and increased the expression of interleukin (IL)‑4, IL‑10, and Forkhead Box P3 in the spleen tissues of hypothyroidism rats. In histological analysis, the administration of MOK pharmacopuncture improved the pathological features in the thyroid glands of hypothyroidism rats. The results suggested that the administration of pharmacopuncture may ameliorate the pathological progression of hypothyroidism by multiple actions, including normalization of the hypothyroidism‑induced thyroid hormone imbalance, stimulation of the antioxidant defense system, and regulation of the T helper (Th)1/Th2 imbalance. Therefore, MOK extract may be used for the treatment of hypothyroidism in Korean clinics as a useful pharmacopuncture medicine.

View Figures

View References

1	Gaberšček S and Zaletel K: Thyroid physiology and autoimmunity in pregnancy and after delivery. Expert Rev Clin Immunol. 7:697–706. 2011. View Article : Google Scholar : PubMed/NCBI
2	Chakera AJ, Pearce SH and Vaidya B: Treatment for primary hypothyroidism: Current approaches and future possibilities. Drug Des Devel Ther. 6:1–11. 2012.PubMed/NCBI
3	Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA and Woeber KA: American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults: Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 22:1200–1235. 2012. View Article : Google Scholar : PubMed/NCBI
4	Korean Acupuncture and Moxibustion Medicine Society: Pharmacopuncture therapyAcupuncture Medicine. Kim JH: Hanmi Medical Publishing co.; Paju: pp. 204–208. 2016, (In Korean).
5	Jung C, Jung JH and Lee MS: PharmacopuncturemedinesA clinical study of immune pharmacopuncturology. Jung C: Kyungrak Medical Publishing Co.; Chungnam: pp. 127–133. 2011, (In Korean).
6	Hwang JH: A case report of Hwa-byeong with MOK Herbal acupuncture therapy. J Immuno-Pharmacopuncture. 2:43–55. 2013.(In Korean).
7	Kim HJ, Gwan R, Han JW, Jung C and Park KH: Analysis of physioactivities on MOK yakchim. J Immuno-Pharmacopuncture. 2:17–25. 2013.(In Korean).
8	Hwang JH, Hwang MS and Park YK: MOK, a pharmacopuncture medicine, reduces inflammatory response through inhibiting the proinflammatory cytokine production in LPS-stimulated mouse peritoneal macrophages. Acupuncture. 34:11–21. 2017. View Article : Google Scholar
9	Hwang JH: Effects of MOK, a pharmacopuncture medicine, on the TH1/TH2 immune response and antioxidation in Con A-stimulated primary mouse splenocytes. Acupuncture. 34:39–48. 2017. View Article : Google Scholar
10	Somers SL: Examining anger in ‘culture-bound’ syndromes. Psychiatric Times. 15:1998.
11	Ashwini S, Bobby Z, Sridhar MG and Cleetus CC: Insulin plant (costus pictus) extract restores thyroid hormone levels in experimental hypothyroidism. Pharmacognosy Res. 9:51–59. 2017. View Article : Google Scholar : PubMed/NCBI
12	Choudhuryl S, Chainyl GB and Mishro MM: Experimentally induced hypo- and hyper-thyroidism influence on the antioxidant defence system in adult rat testis. Andrologia. 35:131–140. 2003. View Article : Google Scholar : PubMed/NCBI
13	Rooney AA, Matulka RA and Luebke RW: Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. Toxicol Sci. 76:366–375. 2003. View Article : Google Scholar : PubMed/NCBI
14	Zamoner A, Barreto KP, Filho DW, Sell F, Woehl VM, Guma FC, Pessoa-Pureur R and Silva FR: Propylthiouracil-induced congenital hypothyroidism upregulates vimentin phosphorylation and depletes antioxidant defenses in immature rat testis. J Mol Endocrinol. 40:125–135. 2008. View Article : Google Scholar : PubMed/NCBI
15	Subudhi U, Das K, Paital B, Bhanja S and Chainy GB: Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats. Life Sci. 84:372–379. 2009. View Article : Google Scholar : PubMed/NCBI
16	Brown RS: Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 5 Suppl 1:S45–S49. 2013.
17	Patricia Wu: Thyroid disease and diabetes. Clin Diabetes Winter. 18:382000.
18	Mullur R, Liu YY and Brent GA: Thyroid hormone regulation of metabolism. Physiol Rev. 94:355–382. 2014. View Article : Google Scholar : PubMed/NCBI
19	Rizos CV, Elisaf MS and Liberopoulos EN: Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 5:76–84. 2011. View Article : Google Scholar : PubMed/NCBI
20	Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, et al: Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab. 92:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
21	Teixeira Pde F, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, Costa AJ and Vaisman M: Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res. 151:224–231. 2008. View Article : Google Scholar : PubMed/NCBI
22	Simon-Giavarotti KA, Giavarotti L, Gomes LF, Lima AF, Veridiano AM, Garcia EA, Mora OA, Fernández V, Videla LA and Junqueira VB: Enhancement of lindane-induced liver oxidative stress and hepatotoxicity by thyroid hormone is reduced by gadolinium chloride. Free Radic Res. 36:1033–1039. 2002. View Article : Google Scholar : PubMed/NCBI
23	Torres S, Díaz BP, Cabrera JJ, Díaz-Chico JC, Díaz-Chico BN and López-Guerra A: Thyroid hormone regulation of rat hepatocyte proliferation and polyploidization. Am J Physiol. 276:G155–G163. 1999.PubMed/NCBI
24	Amin A and Hamza AA: Oxidative stress mediates drug-induced hepatotoxicity in rats: A possible role of DNA fragmentation. Toxicology. 208:367–375. 2005. View Article : Google Scholar : PubMed/NCBI
25	Bhanja S and Chainy GB: PTU-induced hypothyroidism modulates antioxidant defence status in the developing cerebellum. Int J Dev Neurosci. 28:251–262. 2010. View Article : Google Scholar : PubMed/NCBI
26	Messarah M, Saoudi M, Boumendjel A, Boulakoud MS and Feki AE: Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environ Toxicol Pharmacol. 31:33–41. 2011. View Article : Google Scholar : PubMed/NCBI
27	Das K and Chainy GB: Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta. 1537:1–13. 2001. View Article : Google Scholar : PubMed/NCBI
28	Subudhi U, Das K, Paital B, Bhanja S and Chainy GB: Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin. Chem Biol Interact. 173:105–114. 2008. View Article : Google Scholar : PubMed/NCBI
29	Ramsey IS, Delling M and Clapham DE: An introduction to TRP channels. Annu Rev Physiol. 68:619–647. 2006. View Article : Google Scholar : PubMed/NCBI
30	Nilius B, Owsianik G, Voets T and Peters JA: Transient receptor potential cation channels in disease. Physiol Rev. 87:165–217. 2007. View Article : Google Scholar : PubMed/NCBI
31	Wu LJ, Sweet TB and Clapham DE: International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev. 62:381–404. 2010. View Article : Google Scholar : PubMed/NCBI
32	Caterina MJ, Rosen TA, Tominaga M, Brake AJ and Julius D: A capsaicin-receptor homologue with a high threshold for noxious heat. Nature. 398:436–441. 1999. View Article : Google Scholar : PubMed/NCBI
33	Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, et al: Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 136:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
34	Wang H and Siemens J: TRP ion channels in thermosensation, thermoregulation and metabolism. Temperature (Austin). 2:178–187. 2015. View Article : Google Scholar : PubMed/NCBI
35	Liu PW, Blair NT and Bean BP: Action potential broadening in capsaicin-sensitive DRG neurons from frequency-dependent reduction of Kv3 current. J Neurosci. 37:9705–9714. 2017. View Article : Google Scholar : PubMed/NCBI
36	Cesta MF: Normal structure, function, and histology of the spleen. Toxicol Pathol. 34:455–465. 2006. View Article : Google Scholar : PubMed/NCBI
37	Bronte V and Mikael MJ: The spleen in local and systemic regulation of immunity. Immunity. 39:806–818. 2013. View Article : Google Scholar : PubMed/NCBI
38	Kaiko GE, Horvat JC, Beagley KW and Hansbro PM: Immunological decision-making: How does the immune system decide to mount a helper T-cell response? Immunology. 123:326–338. 2008. View Article : Google Scholar : PubMed/NCBI
39	Romagnani S: Biology of human TH1 and TH2 cells. J Clin Immunol. 15:121–129. 1995. View Article : Google Scholar : PubMed/NCBI
40	Murphy KM and Reiner SL: The lineage decisions of helper T cells. Nat Rev Immunol. 2:933–944. 2002. View Article : Google Scholar : PubMed/NCBI
41	Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature. 383:787–793. 1996. View Article : Google Scholar : PubMed/NCBI
42	Ganesh BB, Bhattacharya P, Gopisetty A and Prabhakar BS: Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res. 31:721–731. 2011. View Article : Google Scholar : PubMed/NCBI
43	Barthlott T, Moncrieffe H, Veldhoen M, Atkins CJ, Christensen J, O'Garra A and Stockinger B: CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol. 17:279–288. 2005. View Article : Google Scholar : PubMed/NCBI
44	Setoguchi R, Hori S, Takahashi T and Sakaguchi S: Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 201:723–735. 2005. View Article : Google Scholar : PubMed/NCBI
45	Wan YY and Flavell RA: Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 445:766–770. 2007. View Article : Google Scholar : PubMed/NCBI
46	Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 6:345–352. 2005. View Article : Google Scholar : PubMed/NCBI
47	Belkaid Y: Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol. 7:875–888. 2007. View Article : Google Scholar : PubMed/NCBI
48	Richez C, Barnetche T, Miceli-Rechard C, Blanco P, Moreau JF, Rifkin I and Scharverbeke T: Role for interferon regulatory factors in autoimmunity. Joint Bone Spine. 77:525–531. 2010. View Article : Google Scholar : PubMed/NCBI
49	Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang J, Wang T, Hong S, Guo S, et al: Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab. 305:E485–E495. 2013. View Article : Google Scholar : PubMed/NCBI